Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors
Terry Lee, Alessandro Cau, Matthew P. Cheng, et al.
CJC Open (2021) Vol. 3, Iss. 7, pp. 965-975
Open Access | Times Cited: 19

Showing 19 citing articles:

Cardiovascular complications of COVID-19
Farnaz Farshidfar, Navid Koleini, Hossein Ardehali
JCI Insight (2021) Vol. 6, Iss. 13
Open Access | Times Cited: 131
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19
Genevieve Rocheleau, Terry Lee, Yassene Mohammed, et al.
Critical Care Medicine (2022)
Open Access | Times Cited: 21
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Effects of Renin–Angiotensin System Inhibitors on Mortality and Disease Severity of COVID-19 Patients: A Meta-analysis of Randomized Controlled Trials
Juntao Yin, Chaoyang Wang, Xiaoyong Song, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 5, pp. 462-469
Open Access | Times Cited: 18
Hypertension care during the COVID‐19 pandemic in an integrated health care system
John F. Steiner, J. David Powers, Allen S. Malone, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 4, pp. 315-325
Open Access | Times Cited: 11
Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial
Karen Tran, Pierre Asfar, Matthew P. Cheng, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 3, pp. 615-625
Closed Access | Times Cited: 3
Stratification of hypertension and SARS-CoV-2 infection by quantitative NMR spectroscopy of human blood serum
Jasmin Kazenwadel, Georgy Berezhnoy, Claire Cannet, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, et al.
Revista Portuguesa de Cardiologia (2023) Vol. 42, Iss. 4, pp. 373-383
Open Access | Times Cited: 7
Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction
Roxana Mihaela Chiorescu, Roxana-Daiana Lazar, Sándor-Botond Buksa, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Clinical–Epidemiological Profile of COVID-19 Patients Admitted during Three Waves of the Pandemic in a Tertiary Care Center, in Belém, Pará, Amazon Region of Brazil
Ana Beatriz Nunes Pereira, Fernando Sérgio Henriques Pereira, Júlio Araujo, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1233-1233
Open Access | Times Cited: 1
Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease
Marieta Theodorakopoulou, Maria Eleni Alexandrou, Afroditi Boutou, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 3, pp. 397-406
Open Access | Times Cited: 11
COVID-19 and the heart
Roman Roy, Benedict McDonaugh, Kevin O’Gallagher
British Medical Bulletin (2022) Vol. 144, Iss. 1, pp. 4-11
Open Access | Times Cited: 5
The pathophysiology of COVID-19 and the cardiovascular system
Nazifa Ahsan, Michael O. Adesida, Noorulain Memon, et al.
Elsevier eBooks (2024), pp. 1-17
Closed Access
Emerging Contributions of Endocrine Pathophysiology in Virus-Related Infectious Disease: Focus on the RAAS in COVID-19 and HIV
Teressa S Thomas, Suman Srinivasa
Advances in biochemistry in health and disease (2023), pp. 53-77
Closed Access | Times Cited: 1
Uso previo de antagonistas de la angiotensina II en pacientes hipertensos hospitalizados y mortalidad por COVID-19
Teodoro J. Oscanoa, José Amado, Javier Matta-Pérez, et al.
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo (2022) Vol. 15, Iss. 3, pp. 337-341
Open Access | Times Cited: 1
A koronavírus és a renin-angiotenzin rendszer kapcsolata a COVID-19 elleni gyógyszerek fejlesztésének tükrében
Rudolf Gesztelyi
Egészségügyi Innovációs Szemle (2023) Vol. 2, Iss. 1, pp. 58-67
Open Access
Prior Use of Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and Clinical Outcomes of Sepsis and Septic Shock: A Systematic Review and Meta-analysis
Dhan Bahadur Shrestha, Yub Raj Sedhai, Prakash Raj Oli, et al.
Journal of Cardiovascular Pharmacology (2023)
Closed Access
Einfluss der Corona-Pandemie auf kardiovaskuläre Risikofaktoren – Daten von 1775 Teilnehmern der ELITE Studie vor und während der Corona Pandemie
Paulina Berges, B. Schrader, Bernhard Vaske, et al.
DMW - Deutsche Medizinische Wochenschrift (2023)
Open Access
Pronóstico de los pacientes hospitalizados por Covid-19 que utilizaban inhibidores de la enzima convertidora de angiotensina o antagonistas del receptor de angiotensina II
John Jaime Sprockel Díaz, Luis O. Martinez, Edna Carolina Araque, et al.
Revista Repertorio de Medicina y Cirugía (2021)
Open Access
Page 1

Scroll to top